Characteristics of control subjects and subjects with schizophrenia.

665: Min (12.9) Max (43.2) Avg (28.1) **One Pair Not Shown: HU 1201 (C) and 1189 (S) 802: Min (19.9) Max (37.9) Avg (29) 1222: Min (18.6) Max (43) Avg (30.8)All subject pairs shown were included in analyses of PAK1 and kalirin protein levels. Subject pairs also analyzed for spinophilin protein levels (Observed PMI≤24 hours) are indicated by an asterisk. Control and schizophrenia subjects significantly differed in pH and handedness, but not in age, sex, PMI, and tissue storage time. S/R/A, Sex/Race/Age; PMI, postmortem interval (calculated as lag from midpoint of time last seen alive – time discovered dead to time of brain fixation. [Observed] is calculated as time discovered dead to time of brain fixation); COD, cause of death; Hand, handedness; Meds ATOD, medications used at time of death; ADC, Alcohol Dependence, current at time of death; ADR, Alcohol Dependence, in remission at time of death; AAC, Alcohol Abuse, current at time of death; AAR, Alcohol Abuse, in remission at time of death; ODC, Other Substance Dependence, current at time of death; ODR, Other Substance Dependence, in remission at time of death; OAC, Other Substance Abuse, current at time of death; OAR, Other Substance Abuse, in remission at time of death; L, Left; M, Mixed; R, Right; U, Unknown; B, Benzodiazepines; C, Anticonvulsants; D, Antidepressants; L, Lithium; N, No medications; O, Other medication(s); P,Antipsychotic; U, Unknown.

665：最小值（12.9）、最大值（43.2）、平均值（28.1）；**未展示的配对组：HU 1201（C）与1189（S）**。802：最小值（19.9）、最大值（37.9）、平均值（29）；1222：最小值（18.6）、最大值（43）、平均值（30.8）。所有已展示的受试者配对均纳入PAK1与kalirin蛋白水平的分析。标有星号的受试者配对同时用于spinophilin蛋白水平分析（观测的死后间隔时间≤24小时）。对照组与精神分裂症受试者在pH值与利手性上存在显著差异，但在年龄、性别、PMI、脑组织储存时长上无显著差异。S/R/A：性别/种族/年龄（Sex/Race/Age）；PMI：死后间隔时间（postmortem interval），计算方式为：以最后被目击存活的中点时间至尸体发现时间的时长，与尸体发现时间至脑组织固定时间的时长[观测值]；COD：死亡原因（cause of death）；Hand：利手性（handedness）；Meds ATOD：死亡时使用的药物（medications used at time of death）；ADC：死亡时存在当前酒精依赖（Alcohol Dependence, current at time of death）；ADR：死亡时酒精依赖已缓解（Alcohol Dependence, in remission at time of death）；AAC：死亡时存在当前酒精滥用（Alcohol Abuse, current at time of death）；AAR：死亡时酒精滥用已缓解（Alcohol Abuse, in remission at time of death）；ODC：死亡时存在当前其他物质依赖（Other Substance Dependence, current at time of death）；ODR：死亡时其他物质依赖已缓解（Other Substance Dependence, in remission at time of death）；OAC：死亡时存在当前其他物质滥用（Other Substance Abuse, current at time of death）；OAR：死亡时其他物质滥用已缓解（Other Substance Abuse, in remission at time of death）；L：左利（Left）；M：混合利（Mixed）；R：右利（Right）；U：未知（Unknown）；B：苯二氮䓬类药物（Benzodiazepines）；C：抗惊厥药（Anticonvulsants）；D：抗抑郁药（Antidepressants）；L：锂盐（Lithium）；N：未用药（No medications）；O：其他药物（Other medication(s)）；P：抗精神病药（Antipsychotic）；U：未知（Unknown）。